RHO and breast cancer: RACGAP1 encodes a GTPase-activating protein (GAP), binds activated forms of Rho GTPases and stimulates GTP hydrolysis, which results in negative regulation of Rho-mediated signals, promoting malignant progression in gastric cancer [41], breast cancer [42] and epithelial ovarian cancer [43].